Chapter
WHAT IS A CLINICIAN TO DO?
Chapter 2. Chemoprevention of Prostate Cancer
RATIONALE FOR CHEMOPREVENTION OF PROSTATE CANCER
CHEMOPREVENTION TRIALS IN PROSTATE CANCER
CHEMOPREVENTION AND PROSTATE CANCER RISK
Chapter 3. Update on Prostate Imaging
MAGNETIC RESONANCE IMAGING
Chapter 4. High-intensity Focused Ultrasound: Ready for Primetime
Chapter 5. Overcoming the Learning Curve for Robotic-assisted Laparoscopic Radical Prostatectomy
LEARNING CURVE: THE CHALLENGE OF RADICAL PROSTATECTOMY
TECHNICAL CHALLENGES OF RALP
THE BRIGHAM & WOMEN’S HOSPITAL TECHNIQUE
Chapter 6. The Case for Open Radical Prostatectomy
Chapter 7. Controversies Surrounding Lymph Node Dissection for Prostate Cancer
DETERMINING IN WHOM TO PERFORM PELVIC LYMPHADENECTOMY
EVALUATING THE ROLE OF IMAGING IN IDENTIFYING LYMPH NODE INVASION
EXAMINING THE IMPORTANCE OF THE ANATOMIC TEMPLATE
TAKING INTO ACCOUNT THE SURGICAL APPROACH
ASSESSING THE RATIONALE FOR PELVIC LYMPH NODE DISSECTION
CONTEMPLATING THE RISKS OF PELVIC LYMPH NODE DISSECTION
Primary and Salvage Cryotherapy for Prostate Cancer
FACTORS AFFECTING TISSUE DESTRUCTION DURING CRYOTHERAPY
SURVEILLANCE AFTER CRYOTHERAPY
COMPLICATIONS OF CRYOTHERAPY
Chapter 8. Current Topics in the Treatment of Prostate Cancer with Low-Dose-Rate Brachytherapy
THE DEVELOPMENT OF A REAL-TIME ULTRASOUND-GUIDED IMPLANT TECHNIQUE
BRACHYTHERAPY AND RADIATION DOSE
TRIMODALITY THERAPY FOR HIGH-RISK PROSTATE CANCER
BRACHYTHERAPY-ASSOCIATED MORBIDITY
Chapter 9. Neoadjuvant and Adjuvant Therapies in Prostate Cancer
Chapter 10. Novel Targeted Therapies for Prostate Cancer
ANDROGEN RECEPTOR SIGNALING
VASCULAR ENDOTHELIAL GROWTH FACTOR AND RECEPTOR
INSULINLIKE GROWTH FACTOR-1 RECEPTOR
PHOSPHATIDYLINOSITOL-3-KINASE (PI3K)-AKT SIGNALING PATHWAY
Chapter 11. Immunotherapy for Prostate Cancer: An Emerging Treatment Modality
ACTIVE IMMUNOTHERAPY FOR PROSTATE CANCER
COMBINING CONVENTIONAL THERAPY WITH ACTIVE IMMUNOTHERAPY
IMMUNE MODULATORS (BRAKES AND ACCELERATORS)
Chapter 12. Blood and Tissue Biomarkers in Prostate Cancer: State of the Art
Advances and Controversies in Prostate Cancer, An Issue of Urologic Clinics
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
